{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-000516","form_type":"8-K","ticker":"AGL","cik":"0001831097","company_name":"agilon health, inc.","filed_at":"2024-01-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.812374+00:00","generated_at":"2026-06-07T03:21:51.616585+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"agilon health cuts 2023 medical margin guidance by ~$110M; withdraws 2026 outlook","bullets":["2023 medical margin guidance lowered to $340M-$360M from $455M-$470M, a ~$110M reduction.","2023 Adjusted EBITDA guidance revised to loss of $55M-$69M from prior profit of $6M-$18M.","Higher-than-expected medical costs from specialist visits, Part B drugs, outpatient surgeries cited.","Initial 2024 outlook: medical margin $560M-$600M; Adjusted EBITDA $40M-$60M.","Withdraws previously issued 2026 target; actions underway to improve predictability."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-000516","json":"https://secwatch.observer/filing/0001628280-24-000516.json","markdown":"https://secwatch.observer/filing/0001628280-24-000516.md","text":"https://secwatch.observer/filing/0001628280-24-000516.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831097/000162828024000516/0001628280-24-000516-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831097/000162828024000516/agl-20240105.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T03:21:51.616585+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}